• International recognition for high-performing clinical trial re-cruitment-Multiple sponsor appreciation letters for outstand-ing recruitment and study performance-Recognition for con-tribution to international multicentre clinical trials Recognition following successful GCP quality audits
• Formally recognized by international sponsors for excellence in clinical trial recruitment, first-patient European enrolment, study execution and contribution to multicenter oncology re-search programs.
• Scientific contributions presented at ASCO, ESMO, WCLC, ELCC and other international congresses.
• Established the Clinical Oncology & Clinical Trials rotation at the European Interbalkan Medical Center.
• Responsible for undergraduate bedside teaching and clinical research education.
• Development of structured oncology training pathways for medical students.
• Development of a Fast-Track Oncology Pathway

Clinical Research Leadership

• Recognition of the 4th Oncology Department and Clini-cal Trials Unit as part of the International Early Drug Development Network.
• Co-PI of one of Greece's most active Early Drug Devel-opment and Precision Oncology programs.

International Clinical Trial Milestones

• European First Enrollment Milestone 2026 in Europe in an international Phase IIb Lung Cancer clinical trial.
• European First Enrollment Milestone 2026 in Europe in an international Phase III Prostate Cancer clinical trial.
• Consistently among the highest-enrolling interna-tional clinical trial sites, with leadership in global tho-racic oncology studies.
• Highest-Enrolling Site Worldwide in the international programmeof phase III trial SCLC
• Principal Investigator in 50+ international multicenter Phase I–IV clinical trials
• Highest-Enrolling Site Worldwide in an international Phase Ib pancreatic cancer clinical trial